We are live on ! Find out more
Kayne Anderson Rudnick Investment Management

Kayne Anderson Rudnick Investment Management Portfolio holdings

AUM $34B
1-Year Est. Return 6.31%
This Fund
S&P 500
This Quarter Est. Return
-11.78%
1 Year Est. Return
+6.31%
3 Year Est. Return
+45.79%
5 Year Est. Return
+60.99%
10 Year Est. Return
+604.27%
AUM
$31.7B
AUM Growth
-$5.93B
Cap. Flow
-$473M
Cap. Flow %
-1.49%
Top 10 Hldgs %
17.08%
Holding
706
New
43
Increased
211
Reduced
203
Closed
96

Top Buys

Rank Stock Value
1
AZPN
Aspen Technology Inc
AZPN
+$550M
2
GMED icon
Globus Medical
GMED
+$167M
3
DLB icon
Dolby
DLB
+$165M
4
APAM icon
Artisan Partners
APAM
+$110M
5
BANF icon
BancFirst
BANF
+$104M

Top Sells

Rank Stock Value
1
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$1.19B
2
CDW icon
CDW
CDW
+$176M
3
BILL icon
BILL Holdings
BILL
+$132M
4
OLLI icon
Ollie's Bargain Outlet
OLLI
+$76.7M
5
MGP
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
+$68.1M

Sector Composition

Rank Sector Weight
1 Industrials 27.29%
2 Financials 21.47%
3 Technology 19.81%
4 Healthcare 9.5%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
601
Alnylam Pharmaceuticals
ALNY
$30.4B
– –
-9
Closed -$1K
APD icon
602
Air Products & Chemicals
APD
$67.8B
$0 ﹤0.01%
2
– –
ARGX icon
603
argenx
ARGX
$54B
– –
-13
Closed -$4K
ASND icon
604
Ascendis Pharma A/S
ASND
$16.2B
– –
-30
Closed -$4K
AZN icon
605
AstraZeneca
AZN
$245B
– –
-104
Closed -$14K
BCAB icon
606
BioAtla
BCAB
$5.56M
– –
-3
Closed -$1K
BCE icon
607
BCE
BCE
$21.5B
– –
-182,760
Closed -$10.1M
BCYC
608
Bicycle Therapeutics
BCYC
$282M
– –
-30
Closed -$1K
BMEA icon
609
Biomea Fusion
BMEA
$94.2M
– –
-123
Closed -$1K
BMRN icon
610
BioMarin Pharmaceuticals
BMRN
$13.3B
– –
-44
Closed -$3K
BSX icon
611
Boston Scientific
BSX
$74.5B
– –
-157
Closed -$7K
CASS icon
612
Cass Information Systems
CASS
$750M
$0 ﹤0.01%
1
– –
CNC icon
613
Centene
CNC
$32.8B
– –
-61
Closed -$5K
CNTA
614
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-80
Closed -$1K
COGT icon
615
Cogent Biosciences
COGT
$6.56B
– –
-139
Closed -$1K
COLL icon
616
Collegium Pharmaceutical
COLL
$910M
– –
-71
Closed -$1K
DBC icon
617
Invesco DB Commodity Index Tracking Fund
DBC
$1.72B
– –
-600
Closed -$16K
DGX icon
618
Quest Diagnostics
DGX
$26.1B
– –
-8
Closed -$1K
DOC icon
619
Healthpeak Properties
DOC
$14.3B
– –
-1,158
Closed -$40K
DXCM icon
620
DexCom
DXCM
$34.2B
– –
-28
Closed -$4K
EFV icon
621
iShares MSCI EAFE Value ETF
EFV
$30.1B
– –
-1,463
Closed -$73K
EMBC icon
622
Embecta
EMBC
$288M
$0 ﹤0.01%
+15
New +$432
EPIX
623
DELISTED
ESSA Pharma
EPIX
– –
-97
Closed -$1K
EVGO icon
624
EVgo
EVGO
$516M
– –
-99
Closed -$1K
EW icon
625
Edwards Lifesciences
EW
$53.3B
– –
-40
Closed -$5K
23 24
25
26 27

Similar funds

VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management's Q2 2022 Portfolio in Review

As of Q2 2022, Kayne Anderson Rudnick Investment Management held 706 positions worth $31.7B, down 16% from $37.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Kayne Anderson Rudnick Investment Management's Q2 2022 filing shows 43 new, 211 increased, 203 reduced and 96 closed positions. Its largest new stake was Aspen Technology Inc: 3,094,432 shares worth $568M. The largest sale was ASPEN TECHNOLOGY INC, an estimated $1.19B.

By sector, the portfolio is most concentrated in Industrials at 27% of assets, up from 26% a quarter earlier, followed by Financials and Technology.

  • Kayne Anderson Rudnick Investment Management's largest Q2 2022 buy was Aspen Technology Inc: 3,094,432 shares worth $568M.
  • Kayne Anderson Rudnick Investment Management added most to Globus Medical in Q2 2022, an estimated $167M increase.
  • Kayne Anderson Rudnick Investment Management's biggest Q2 2022 reduction was CDW, cutting an estimated $176M.
  • Kayne Anderson Rudnick Investment Management fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $1.19B.
  • Kayne Anderson Rudnick Investment Management's ten largest holdings make up 17% of its $31.7B portfolio in Q2 2022.
  • Kayne Anderson Rudnick Investment Management opened 43 new positions and closed 96 in Q2 2022.
  • Kayne Anderson Rudnick Investment Management's portfolio value fell 16% quarter-over-quarter to $31.7B.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.